ArticleCancers2023

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.

Valentina Tuninetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.